Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II by Des Jarlais, Don C et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Public Health
Open Access Case report
Using standardized methods for research on HIV and injecting drug 
use in developing/transitional countries: case study from the WHO 
Drug Injection Study Phase II
Don C Des Jarlais*1, Theresa E Perlis1, Gerry V Stimson2, Vladimir Poznyak3 
and the WHO Phase II Drug Injection Collaborative Study Group
Address: 1Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, 160 Water Street, 24th Floor, New York NY 
10038, United States. Also at The Center for Drug Use and HIV Research, National Development and Research Institutes Inc., New York, NY 10010, 
USA, 2Executive Director, International Harm Reduction Association. Also at the Centre for Research on Drugs and Health Behaviour, Imperial 
College of Medicine, St Dunstan's Road, London W6 8RP, UK and 3World Health Organization, Management of Substance Dependence, CH-1211 
Geneva 27, Switzerland
Email: Don C Des Jarlais* - dcdesjarla@aol.com; Theresa E Perlis - tperlis@chpnet.org; Gerry V Stimson - g.stimson@imperial.ac.uk; 
Vladimir Poznyak - poznyakv@who.int
* Corresponding author    
Abstract
Background: Successful cross-national research requires methods that are both standardized
across sites and adaptable to local conditions. We report on the development and implementation
of the methodology underlying the survey component of the WHO Drug Injection Study Phase II
– a multi-site study of risk behavior and HIV seroprevalence among Injecting Drug Users (IDUs).
Methods: Standardized operational guidelines were developed by the Survey Coordinating Center
in collaboration with the WHO Project Officer and participating site Investigators. Throughout the
duration of the study, survey implementation at the local level was monitored by the Coordinating
Center. Surveys were conducted in 12 different cities. Prior rapid assessment conducted in 10 cities
provided insight into local context and guided survey implementation. Where possible, subjects
were recruited both from drug abuse treatment centers and via street outreach. While emphasis
was on IDUs, non-injectors were also recruited in cities with substantial non-injecting use of
injectable drugs. A structured interview and HIV counseling/testing were administered.
Results: Over 5,000 subjects were recruited. Subjects were recruited from both drug treatment
and street outreach in 10 cities. Non-injectors were recruited in nine cities. Prior rapid assessment
identified suitable recruitment areas, reduced drug users' distrust of survey staff, and revealed site-
specific risk behaviors. Centralized survey coordination facilitated local questionnaire modification
within a core structure, standardized data collection protocols, uniform database structure, and
cross-site analyses. Major site-specific problems included: questionnaire translation difficulties;
locating affordable HIV-testing facilities; recruitment from drug treatment due to limited/selective
treatment infrastructure; access to specific sub-groups of drug users in the community, particularly
females or higher income groups; security problems for users and interviewers, hostility from local
drug dealers; and interference by local service providers.
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Conclusion:  Rapid assessment proved invaluable in paving the way for the survey. Central
coordination of data collection is crucial. While fully standardized methods may be a research ideal,
local circumstances may require substantial adaptation of the methods to achieve meaningful local
representation. Allowance for understanding of local context may increase rather than decrease
the generalizability of the data.
Background
While the injection of illicit psychoactive drugs has tradi-
tionally been associated with industrialized countries,
particularly the US [1], the problem is increasing rapidly
in developing and transitional countries. The most recent
estimate of the numbers of injecting drug users (IDUs)
found that 10 million of the 13 million estimated IDUs
live in developing and transitional countries [2]. Injecting
drug use can create multiple serious health and social
problems in developing and transitional countries. The
spread of HIV through the multi-person use (sharing) of
needles and syringes for drug injecting is among the most
dramatic and potentially catastrophic of these problems
[3].
Rapid implementation of HIV prevention programs for
IDUs is needed to address the problem of HIV transmis-
sion among IDUs in developing/transitional countries.
Additional research is also needed in order to assess the
specific prevention needs, to adapt existing programs to
the local situation, and to assess the effectiveness of the
implemented programs. Further research is also needed to
develop generalizable knowledge that could be used to
increase the effective use of the scarce resources available
for preventing HIV infection among IDUs in developing
and transitional countries.
Conducting research on HIV infection and HIV risk
behaviors among IDUs in developing and transitional
countries involves overcoming many difficulties, from
contacting "hard to reach" populations to a limited
research infrastructure. The use of "standardized" research
methods across different sites is one of the more powerful
tools for developing generalizable knowledge in epidemi-
ology. The first WHO Multi-site Study of HIV and Inject-
ing Drug Use (WHO Phase I), conducted from 1989
through 1993 [4], was one of the first studies that utilized
standardized methods for collecting data in both
resource-rich and resource-constrained countries, though
the majority of sites were in resource-rich countries. This
study produced a number of important findings with
respect to preventing HIV infection among IDUs, includ-
ing: 1) that IDUs were capable of changing their behavior
to reduce the risk of HIV infection, and this behavior
change had a strong protective effect against becoming
infected [5], and 2) if effective prevention programming
was implemented early and on a large scale, it was possi-
ble to avert epidemics of HIV among IDUs [6]. However,
one of the major drawbacks of the study was the lack of
qualitative contextual assessment.
The purpose of this paper is to report on the survey
research methods used in the second phase of the World
Health Organization Multi-Site Study of HIV/AIDS and
Injecting Drug Use (WHO Drug Injection Study Phase II).
This has been the largest study to utilize standardized
methods to investigate HIV infection and risk behaviors
among IDUs in developing and transitional countries. We
wish to provide a reasonably detailed description of the
methods in order that 1) persons examining data from the
study will have a resource for understanding how the data
were collected, 2) other researchers may utilize (and
adapt) these methods for use in new studies, and 3) to
illustrate some of the complex issues in using standard-
ized methods across a wide variety of international sites.
Methods
The WHO Drug Injection Study Phase II was undertaken
from 2000 to 2004, and extended the aims of WHO Phase
I to include study of transition from non-injecting to
injecting drug use, investigation of overdose and other
adverse health consequences of drug use, and estimation
of hepatitis B and C prevalence among injecting drug
users. This second study was specifically designed to
incorporate a rapid assessment and response (RAR) com-
ponent in addition to a cross-sectional seroprevalence and
risk behavior survey of injecting drug users. The purpose
of RAR was to implement methods for speedy research to
keep pace with the rapid spread of HIV, to inform further
in-depth studies where needed, and to encourage early
intervention. (A technical guide to RAR can be found on
the web [7].) The subsequent survey component, while
designed to be similar to the survey conducted in Phase I,
thus had the advantage of being able to draw on informa-
tion obtained during the RAR. In contrast to WHO Phase
I, the Phase II study was designed to be conducted solely
in resource-constrained countries.
Twelve cities participated in the WHO Drug Injection
Study Phase II survey including two, Rio de Janeiro and
Santos in Brazil, that were also part of WHO Phase I. New
cities included Lagos (Nigeria) and Nairobi (Kenya) in
Africa, Beijing (China), Hanoi (Vietnam), and Penang
(Malaysia) in Asia, Kharkiv (Ukraine), Minsk (Belarus)BMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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and St. Petersburg (Russia) in Eastern Europe, Bogotá
(Colombia) and Gran Rosario (Argentina) in South Amer-
ica. (Madras in India was also selected to participate but
withdrew early in the study. Tehran in Iran joined the
project approximately a year after the other cities, but had
completed only the rapid assessment component at the
time of writing.)
Study coordination
Overall project management was carried out by the
Department of Mental Health and Substance Depend-
ence, WHO (WHO/MSB). Additionally, two coordinating
Centers were established to work in cooperation with the
WHO/MSB Study Team. The Centre for Research on Drugs
and Health Behaviour at Imperial College School of Med-
icine in London was responsible for the RAR component
and the NYC Survey Coordinating Center (NYC-SCC) of
National Development and Research Institutes, Inc., and
The Baron Edmond de Rothschild Chemical Dependency
Institute, Beth Israel Medical Center in New York City was
responsible for the multi-city questionnaire and seroprev-
alence survey. (Detailed information concerning the
implementation of the rapid assessment component in
the study has been described elsewhere[8,9].)
Participating site selection
Based on recommendations from the Phase I study for
future research to include representation from Africa,
Eastern Europe, Latin and South America, the Caribbean,
and parts of Asia in order to study a broader range of cul-
tural environments, proposals were solicited from
research institutions or agencies in these geographic areas.
Potential participants were selected by the WHO/MSB
team based on the scope of the local HIV epidemic among
IDUs, and the presence of experienced investigators with
access to resources to undertake both the RAR and the
questionnaire and seroprevalence survey. Proposal guide-
lines issued by WHO/MSB covered the following: back-
ground and rationale for inclusion of the site in the study;
qualifications of the investigating team and implement-
ing agency; aim, scope, and duration of the project; plans
for RAR and survey implementation, evaluation, and
monitoring; expected project outputs and plans for utili-
zation; partners and alliances; resources and budget; and
procedures for local ethical clearance.
Planning meeting
In September, 2000, after selection of most of the partici-
pating sites, a 4-day planning meeting was held in St.
Petersburg, Russia. This was attended by the WHO/MSB
project team, the Coordinating Center teams, and repre-
sentatives from all participating cities except Nairobi
which had not yet been selected at that time. The meeting
provided an opportunity for training in all aspects of the
survey and for resolution of problems and modifications
to the questionnaire and survey process based on feed-
back from the investigators. Additional training in the
rapid assessment and survey components was subse-
quently organized for the three East European research
teams.
Local partners and alliances
A wide variety of organizations and individuals collabo-
rated with the Implementing Agencies and the Principal
Investigators in planning and conducting the survey.
Arrangements were made by each participating site indi-
vidually. Limited funding was supplied by WHO/MSB,
supplemented by additional funds obtained locally. Advi-
sory committees, technical expertise in the areas of survey
implementation, serology testing and statistical analysis,
and assistance with identification of recruitment locations
and fieldwork were drawn from academic institutions,
medical facilities, local or national government authori-
ties, non-governmental organizations, law enforcement
units, and drug users.
Responsibilities of the NYC survey coordinating center
In the Phase I study, despite the standardized survey
methodology developed specifically for the study, lack of
centralized coordination resulted in unilateral adaptation
of survey procedures and difficulties in merging the data-
sets, thus limiting the potential for comparative analyses.
The aim in Phase II was to build on and adapt the Phase I
protocol to ensure adherence to standardized procedures
and uniformity of data collection, while providing maxi-
mum flexibility to individual participating sites to adapt
the protocol to local conditions.
Duties of the NYC-SCC included:
1. Review of proposals from prospective investigators.
2. Development of the overall survey protocol from Phase
I and preparation of operational guidelines for sampling,
recruitment, interviewing using a structured question-
naire, HIV testing and counseling, and data management.
(A copy of the Operations Manual is available on the
WHO project website [10].)
3. Revision of the WHO Drug Injecting Study Phase I sur-
vey questionnaire, incorporating suggestions from WHO/
MSB and from potential WHO study collaborators or con-
sultants, to create a modified questionnaire prototype
with flexibility for local adaptation.
4. Organization of training workshops in Survey Methods.
5. Provision of technical support to participating sites in
a) adaptation of the prototype questionnaire for local use;BMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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b) development of local study protocols, while ensuring
their consistency with the overall study protocol.
6. Supervision of sampling, quality control, data collec-
tion and registration, ensuring cross-city compatibility.
7. Compilation and checking of data from the participat-
ing sites, and maintenance of the central dataset
8. Analysis of multi-site data.
Responsibilities of participating sites
Following guidelines issued by the NYC-SCC and utilizing
information and experience gained during the rapid
assessment, each site was required to plan the local survey
operations, adapt and translate the prototype question-
naire (prepared by NYC-SCC team) for local use, hire and
train fieldworkers, pilot the questionnaire, identify
recruitment locations, develop local sampling/recruit-
ment protocols, recruit and interview subjects, select lab-
oratory facilities and arrange for HIV serotesting of all
interviewed subjects, enter questionnaire data into a com-
puter database for forwarding to the NYC-SCC, and pre-
pare interim and final reports on the survey.
Ethical procedures
Principal Investigators and the Implementing Agencies
were required to be familiar with the International Guide-
lines for Ethical Review of Epidemiological Studies [11],
and to adhere to the principles described therein. Each
participating site was required to submit their study pro-
tocol for review by a local Ethics Board composed of local
scientists, researchers, representatives of NGOs, and oth-
ers, and to prepare an informed consent information
sheet to show (or read) to subjects to ensure that they
were made aware of possible implications of participation
in the research. The operational guidelines specified that
the consent form should include: i) the right to refuse par-
ticipation; ii) the right to withdraw from participation at
any time without adverse consequences; iii) a statement
emphasizing that participation was voluntary; iv) specifi-
cation of a contact person to discuss/explain details of
project; and v) assertion of confidentiality. Unless the
local Ethics Board recommended that oral consent would
be preferable for maintaining confidentiality, written con-
sent was required of study recruits.
Overall survey protocol and design
The primary focus of the study was on injecting drug use,
thus each participating site was asked to try to recruit 400
current injectors, with a minimum of 100. The target of
400 was based on experience from WHO Phase I. The
locally-adapted structured questionnaire was adminis-
tered by a trained interviewer to each eligible recruit. Sub-
sequently each subject was asked to provide a blood
sample for HIV (and in some cases HBV and HCV) testing.
Although drug treatment programs provide a readily
accessible pool of potential recruits for a drug study, the
restrictive admittance criteria (e.g., high fees, HIV negative
status) employed by some programs limit treatment to
specific subgroups of drug users. Moreover, many drug
users do not seek treatment. Thus in order to obtain broad
coverage of injectors and reduce the bias associated with
recruitment from treatment programs only, it was recom-
mended that recruitment be carried out both from treat-
ment program settings and from community or other
non-treatment settings. The purpose of including subjects
from both treatment and community settings was not to
compare drug users entering treatment with those who
did not seek, or lacked access to, treatment, but rather to
provide findings that were generalizable across a broad
range of IDUs. However, it should be noted that although
comparison of subjects recruited from each source was
not an analytic focus at the global level, such comparisons
do provide a methodological check of bias at the city level.
In order to effectively target subsequent interventions,
examination of reasons for transition from non-injecting
to injecting drug use and understanding of reasons for dif-
ference in prevalence levels of drug injecting behavior in
similar and geographically close cities was needed. Thus,
in geographic areas where injection drug use was on the
increase or where use of "injectable" drugs by non-
injected modes of administration was widespread, indi-
vidual sites were encouraged to also recruit persons who
had replaced injection drug use with non-injection
(former injectors), and/or persons who had never injected
(never-injectors) in the study. These persons could be
recruited from treatment and/or community settings as
desired, however, a minimum of 100 former or 100 never-
injectors was recommended.
Eligibility for survey enrollment
Since most of the questionnaire sections on drug use and
risk behaviors covered the 6-month period preceding
study recruitment, it was decided to limit recruitment
from treatment settings to clients newly-admitted to a
treatment program within the past 30 days, since such cli-
ents could be considered to have been "part of the com-
munity" for most of the six-month period. Accordingly
the questionnaire items would apply equally to both com-
munity and treatment recruits. Apart from the current
course of treatment, the subject should not have been in
that same treatment program or any other treatment pro-
gram during the preceding 6 months. Community recruits
could be drawn from any non-treatment settings, prefera-
bly from street locations. If a person recruited from a com-BMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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munity setting was currently attending drug treatment this
did not render him/her ineligible as a community recruit.
All sites were required to recruit current injectors, but
recruitment of former or never-injectors was optional
depending upon the local situation. The criteria for each
category were:
a) Current injectors must have injected during the last 2
months
b) Former injectors had to have some history of injection
but no injected drug use during the preceding 6 months in
order to demonstrate a serious commitment to injection
cessation. However they had to have used non-injection
methods for "injectable" drugs during the preceding 2
months.
c) Never-injectors were persons who had never injected in
their lifetime. However, they had to have used non-injec-
tion methods for "injectable" drugs during the preceding
2 months.
Finally, no subject could be recruited into the study more
than once.
These selection criteria aimed at ensuring comparability
across cities in different cultural environments and at dif-
ferent time periods. The term "injectable" was originally
conceived to include drugs such as heroin, cocaine, and
other commonly injected drugs. However, during rapid
assessment the Bogotá team encountered instances of
alcohol injection; from then on "injectable" was defined
to cover any substance that anyone injected outside of a
medical context.
Selection and training of field staff
Field staff were drawn from a variety of backgrounds, from
health-care professionals to NGO staff to recovering drug-
dependent persons. Training for field workers was con-
ducted following guidelines prepared by the NYC-SCC,
although each participating site assumed responsibility
for the precise nature and duration of the training ses-
sions. Typically training lasted between two and five days
and covered all aspects of recruitment and questionnaire
administration, informed consent procedures, principles
of communication with IDUs, safety issues for field work-
ers, record keeping, and data management.
Sampling procedures and recruitment of subjects
Owing to the vastly different situations across cities, a uni-
form approach to sampling and recruitment was not con-
sidered feasible. Overall guidelines were provided, but the
ultimate decision on design and implementation of local
sampling and recruitment protocols was made by each
site investigator in consultation with the Survey Coordi-
nating Centre.
Selection of treatment programs
During the rapid assessment investigators identified treat-
ment programs or other institutions providing drug treat-
ment (such as psychiatric institutions) and gathered data
on service capability, patient turnover and "typical"
patients. This information was used to determine whether
recruitment from treatment programs was feasible and, if
so, how many and which treatment programs should be
included in the survey in order to provide the required
sample size. It was also necessary to ensure that treatment
staff would cooperate, or, in some instances, actually help
to recruit. In most cities, treatment programs were selected
based on size of the intake population and the ease of
access to the target groups. Since it was important to avoid
any selection bias on the part of the investigators, data col-
lectors, or subjects, the project guidelines indicated that, if
possible, subjects should be randomly selected from all
newly admitted patients. Where random selection was not
feasible (due primarily to small numbers of incoming
patients), sequential new admits were screened for eligi-
bility and all meeting the criteria were invited to partici-
pate in the survey.
Identification of community locations
Rapid assessment findings from in-depth interviews,
focus groups, informal discussions, direct observation in
natural settings, anonymous self-administered question-
naires, and geographic mapping were used to target loca-
tions most likely to yield potential subjects. In most cities
repressive local policies about drug use and stigmatization
of HIV-infected persons resulted in IDUs being a "hidden"
population. Since random selection of subjects in the
community was not feasible, techniques such as peer-
referral, snowball sampling, and targeted sampling, were
used in order to access the hidden populations. Investiga-
tors were instructed to make every effort to obtain a sam-
ple representative of the non-treatment population in the
area.
Questionnaire
Design
In order to maintain a high degree of continuity with the
questionnaire from the first Drug Injecting Study and per-
mit temporal comparisons in cities which participated in
both phases, some sections or items from the Phase I
questionnaire were duplicated in the questionnaire proto-
type prepared for the second study. However, to make
space for new material, some previous sections had to be
eliminated or reduced in length in order to avoid a pro-
hibitively long new questionnaire. Sections in the modi-
fied questionnaire were classified as either "core" (to be
included in questionnaires at all participating sites) orBMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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"local option" (to be included or excluded at the discre-
tion of the local investigator).
Review process
Initial drafts of the revised questionnaire were sent to the
WHO/MSB Project Officer, Principal Investigators from
WHO Phase I, and other researchers throughout the
world. Comments and suggestions were received from
collaborators or consultants in Brazil, China, Colombia,
Denmark, Greece, Italy, Netherlands, Nigeria, Russian
Federation, Spain, Thailand, Ukraine, United Kingdom,
and the United States. Subsequent drafts were reviewed in
a WHO meeting in London and were also selectively pre-
tested in New York and Bangkok. Reviewers' comments
covered the spectrum, including: too long; not enough
detail; use three different questionnaires (one for current
injectors, one for former injectors, and one for never-
injectors); split the questionnaire into one short section
containing essential questions, and one longer section to
administer to subjects willing to spend the time; place a
greater focus on global diversity in substances used,
behaviors, environments; and provide for the inclusion of
questions targeting local behaviors or activities. An
attempt was made to try to incorporate all suggestions
made by at least two reviewers and to allow for more local
modification and additions. Site-specific flexibility was
built into many questions so that additional items could
be added to multi-item questions, or additional response
categories added to individual items. A penultimate ver-
sion of the Phase II questionnaire was field-tested in Rio
de Janeiro and Santos.
Final questionnaire
Core sections included demographics, injection drug use
and associated behaviors, sexual behaviors, travel, HIV
and AIDS awareness and behavior change, medical his-
tory, service utilization, witnessed overdose, and HIV test-
ing prior to interview. Local option sections covered non-
injecting drug use, injection initiation, last injection
event, drug roles, hepatitis, experienced overdose, and
involvement in violence. (A copy of the questionnaire
may be obtained from the primary author, Dr. Des Jarlais,
or the second author, Dr. Perlis.)
Local adaptation
The Principal Investigator at each participating site was
responsible for adapting the questionnaire to reflect local
circumstances by adding new items or questions or
expanding the response range. Technical support was pro-
vided by the NYC-SCC team to ensure consistency with
the research protocol for the whole study. Local modifica-
tions to the questionnaire were based partially on extant
knowledge and partially on information collected during
the rapid assessment stage. For example, categories of
drug treatment and types of drugs used varied substan-
tially across geographic regions. Moreover, in some cities,
the presence of repressive law enforcement policies
resulted in local risk behaviors not observed elsewhere.
Translation
Translation of the questionnaire was carried out locally at
each site, – into Mandarin in Beijing, Vietnamese in
Hanoi, Malay in Penang, Spanish in Bogotá and Rosario,
and Portuguese in Rio de Janeiro and Santos. The three
Eastern European countries collaborated on translation
into Russian. Unfortunately, limited resources precluded
back-translation. In Nairobi and Lagos the English version
was used, but in the latter city interviewers interpreted as
needed, due to the numerous different languages used in
that area.
Seroprevalence component
Serum samples were collected in all participating cities
except Penang. The remaining eleven participating cities
conducted testing for HIV, hepatitis B, and hepatitis C.
Centralized data coordination
In order to ensure comparability of data across sites, all
locally adapted questionnaires were required to conform
to a uniform question numbering structure. A data entry
system for the questionnaire prototype was designed by
NYC-SCC using Epi Info™ version 6.04, and customized
for each site that wanted to use Epi Info™ for its locally
modified questionnaire For other sites preferring to set up
their own data entry system (in SPSS® or SAS®), a protocol
specifying variable names, variable types, and data file for-
mats was issued. Each site was asked to submit a small
pilot data set (typically 10 cases) for checking and
approval by the NYC-SCC before data-entering the full set
of questionnaire data. When final complete data sets were
submitted, NYC-SCC performed validity checking,
requested corrections where necessary, then merged all
datasets into one master dataset.
Utility of RAR in planning and carrying out the survey
During the rapid assessment information was gathered
from a wide variety of informal sources, including IDUs,
other drug users, members of IDUs' social networks, drug
dealers, non-users in contact with users in dealing and
drug-using locations, students (high school and technical
school), and formal sources including education system
representatives, drug treatment specialists/agencies,
health promotion programs and outreach teams, local
health services, hospital emergency rooms, community
leaders, law enforcement personnel, and local/national
government officials. Modes of data collection included
structured interviews using brief questionnaires, semi-
structured interviews, direct observation in the field,
informal interviews, focus groups, secondary data analy-
sis, and content analysis of media publications. In indi-BMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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vidual cities the rapid assessment became an important
tool in planning survey procedures such as recruitment
and interviewing at the local level, modifying the ques-
tionnaire to reflect the local situation, and training of sur-
vey field staff.
Results
Overall recruitment
A total of 3350 current injectors and 1844 former or
never-injectors meeting eligibility criteria were recruited
(Tables 1a and 1b). Ten cities recruited from both treat-
ment and community settings, however only Hanoi and
the three Eastern European cities were able to reach the
proposed recruitment goal of approximately 200 current
injectors from each of the settings. Former injectors were
recruited in nine cities (although the sample size in Bei-
jing was very small), and never-injectors in seven cities.
However, in some cities such recruitment occurred unin-
tentionally due to lack of adherence to recruitment criteria
resulting in erroneous recruitment of "current" IDUs who
were later reclassified as former or never injectors. Addi-
tionally some recruits reported their last injection as being
between 3 and 6 months prior to recruitment, thus failing
to meet the study criteria for current or for former injec-
tors, and had to be dropped from the analyses. (These per-
sons are not included in the totals shown above.) In the
South American cities cocaine was the typical drug of
abuse, whereas heroin or other opiates were the primary
drugs in all of the other cities except for Lagos where both
heroin and cocaine featured prominently.
Treatment recruitment
During the rapid assessment it became apparent that
Lagos and Bogotá would not be able to recruit any current
IDUs from treatment programs. In Lagos there were very
few treatment opportunities and these were reserved for
Table 1a: Total Recruitment
Africa Asia
Lagos Nairobi Beijing Hanoi Penang
Total 386 348 377 763 228
Treatment
Current IDUs ~ 4 323 300 30
Former IDUs ~ 1# 6# 12# 35#
Never IDUs ~ 10# ~9 # 10#
Community
Current IDUs 45 102 43 345 91
Former IDUs 29 49# 5# 39 31#
Never IDUs 312 182 ~ 58 31#
~ indicates that no recruitment was attempted by design
# Originally recruited as current injectors but subsequently reclassified.
## Recruitment source unknown for 4 IDUs and 1 former IDU recruited in Rosario
Table 1b: Total Recruitment
Eastern Europe South America
Kharkiv Minsk St. Petersburg Bogota Gran 
Rosario##
Rio de Janeiro Santos
T o t a l 4 3 84 0 04 0 03 0 16 0 55 8 63 6 2
Treatment
Current IDUs 188 201 197 ~ 6 6 1
F o r m e r  I D U s ~~~~ 1 7 8 69
N e v e r  I D U s ~~~~ 4 6 1 6 2 0
Community
Current IDUs 250 199 203 237 319 183 73
Former IDUs ~ ~ ~ 64 115 261 82
N e v e r  I D U s ~~~~ 9 7 3 4 1 7 7
~ indicates that no recruitment was attempted by design
# Originally recruited as current injectors but subsequently reclassified.
## Recruitment source unknown for 4 IDUs and 1 former IDU recruited in RosarioBMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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the wealthy. In Bogotá, although a prior local survey had
identified over 82 drug treatment programs, analysis of
the WHO rapid assessment data indicated that most per-
sons admitted to drug treatment did not have a history of
injection and only 2% to 3% of new admittances reported
having tried injection even once or twice. The Bogotá team
thus changed their survey plan to conduct community
recruitment only. Similarly, rapid assessment in Rosario
revealed a poor treatment infrastructure and evidence that
injectors were typically not in treatment, partially due to
the abstinence-based focus of most treatment programs.
However, the Rosario team decided to attempt treatment
recruitment by including all area treatment programs with
any record of attendance by IDUs.
Although selection of treatment programs for inclusion in
the study was primarily based on size of patient popula-
tion, the type of treatment institution varied by site (Table
2). In the Asian countries, where drug use is highly crimi-
nalized, most study subjects were recruited from the large
compulsory long-term rehabilitation programs. In Eastern
Europe (where only current injectors were recruited) free
drug treatment requires that the patient be officially regis-
tered as a person with a drug use disorder – thus many
users prefer to pay for private treatment or to avoid treat-
ment altogether.
Recruitment was typically carried out by study research
staff, with assistance from program staff in some cities.
Once the survey was underway, recruitment of current
IDUs proved more difficult than anticipated from treat-
ment programs in Nairobi, Penang, and the South Ameri-
can cities. In Nairobi, an attempt to recruit subjects from
treatment settings yielded low turnout. Addicts entering
the rehabilitation programs in Penang are typically man-
dated by the court to undergo rehabilitation at the pro-
gram for 18–24 months, thus the turnover rate is rather
slow and study recruitment was low. In the South Ameri-
can cities drug treatment was both relatively scarce, and
primarily available only for non-injecting drug users, lim-
iting recruitment possibilities.
Community recruitment
Recruitment from community settings proved more diffi-
cult than anticipated in Lagos, Nairobi, Beijing, Penang,
and Santos. In many cities key informants or "gatekeep-
Table 2: Treatment Recruitment
Compulsory Drug 
Treatment
Voluntary Private Drug 
Treatment
Voluntary Public 
Drug Treatment
Other
Africa Nairobi Residential drug treatment 
in National Psychiatric 
clinic#
Private residential drug 
treatment clinics
Asia Beijing Detoxification Center
Hanoi Rehabilitation center for sex 
workers Rehabilitation 
center for drug users
Penang Long-term rehabilitation for 
drug users
Eastern Europe Kharkiv City Detoxification Clinic City Detoxification 
Clinic
Minsk Minsk Narcological Dispensary Minsk Narcological 
Dispensary
St. Petersburg City Narcological 
Hospital
Psychiatric hospitals 
providing unofficial 
drug treatment
South America Gran Rosario Inpatient and outpatient 
therapeutic communities 
(typically religion-oriented) 
Outpatient drug clinics Drug 
treatment units in private 
psychiatric clinics and general 
hospital
Outpatient drug clinic 
Drug treatment unit 
in City Mental Health 
hospital
Rio de Janeiro Outpatient drug treatment 
Residential drug treatment
Santos Outpatient drug treatment 
Residential drug treatment
# Most patients are admitted involuntarilyBMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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ers" who had assisted with the rapid assessment stage con-
tinued to assist with survey recruitment. Even in cities
where the survey utilized new field staff, the carryover of
the study "presence" from the rapid assessment stage facil-
itated survey recruitment greatly. In some cities, monetary
incentives (Beijing, Lagos, Nairobi) or transportation
expenses (Bogotá, Rio) were provided. The snowball sam-
pling technique was typically used to recruit study sub-
jects.
In most cities, many drug users came originally from mid-
dle (or even upper) income families. Except in the city of
Lagos, almost all study subjects lived in relatively stable
housing (their own or with family or friends), and
approximately 50% or more of the study subjects in all cit-
ies engaged in some form of permanent or temporary
work. Based on individual site reports, a brief description
of community recruitment is provided for each site sepa-
rately.
Lagos
Four of the twenty local government areas in Lagos State
were selected based on known high level of drug activities,
including the presence of a considerable number of drug
selling points (so-called "joints") and drug users. This was
the only city in the study in which large numbers of the
users were homeless (living in the "joints", uncompleted
buildings, in the market or other outdoor places), existing
on money from temporary jobs or begging.
Nairobi
Similar to the approach in Lagos, four residential areas
were selected based on high activity of drug use and sales:
the City Center (located in the business district), Eastlands
(a mix of low to middle class residential and business
areas), Westlands (a mix of low-income and affluent
groups), and peri-urban locations where the majority of
heroin users were drivers and touts operating mini buses
to and from the city center. In Nairobi most drug users
worked to support themselves, and almost three quarters
of the Nairobi recruits were engaged in some form of
work, primarily temporary jobs.
Beijing
Rapid assessment had found that many drug users were
small or large scale business owners selling a diverse range
of goods and services including, travel, clothing, ciga-
rettes, property, marketing, cotton and hay, computers,
and mobile phones. Community recruitment of drug
users proved particularly difficult in Beijing – only 50
recruits over several months of effort. Rapid assessment
revealed that drug users frequently prefer to use in the pri-
vacy of their own homes (to reduce the risk of arrest), and
that many injectors prefer to inject alone. Furthermore the
huge travel distances within Beijing city hindered access to
existing drug user networks. Thus peer and key informant
referral (particularly drug dealers) proved to be a more
successful strategy than snowball sampling. Regrettably,
key informants, potential recruiters and subjects all feared
arrest, inhibiting study recruitment. Moreover, many drug
users appeared to be relatively wealthy and therefore not
interested in the monetary incentive offered for study par-
ticipation. Indeed, over a quarter of the recruits reported
that they were living on savings.
Hanoi
Cluster sampling of persons from communes within dis-
tricts with high numbers of drug users (according to the
official registry of drug users maintained by the Provincial
Sub-Departments for Social Evils Control) was used to
ensure geographic coverage of the city. Initially five of the
highest drug-use urban districts were selected, followed by
selection of five of the highest drug-use communes in
each district. Within each commune, an initial drug user
was chosen by the peer educator from the local HIV/AIDS
program, with subsequent drug users selected by snowball
sampling. While many drug users worked at temporary
jobs or family businesses, almost one third of community
recruits were primarily supported by friends or relatives.
Penang
The selection of specific recruitment areas was based on
information provided by the police and the National Nar-
cotics Agency. One such area was a fishing village, where
it was believed that drugs were easily obtained via the sea.
Unlike the other cities, practically all drug users were
working (many were fishermen) and none of the study
recruits were supported by friends or family. Over 90% of
the recruits classified themselves as middle or upper class.
Official statistics in Malaysia indicate that female drug
users are very rare, and none were actually recruited for
the study.
Kharkiv
According to rapid assessment reports, IDUs are to be
found in all areas of the city, with concentrations in areas
around student and workers' hostels. The survey covered
four districts in the city where drug injection activity was
known to be high: Moskovskiy (the large central district),
Frunzenskiy (industrial and poor), Kominternovskiy
(mixed, containing a number of high educational institu-
tions and hostels), and Dzerdzinskiy (mixed, located at
the crossing of different districts, containing a number of
high educational institutions and hostels). Both registered
and non-registered IDUs were targeted. A large number of
subjects (80%) reported some form of employment,
although much of this was unskilled or temporary work.BMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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Minsk
Initially, the Minsk research team obtained epidemiologi-
cal data for all districts on overdose rates, reported
number of drug-dependent persons and current rate of
change, HIV and HBV infections, and drug trafficking
crimes, and used these data to rate districts by high, aver-
age, or low levels of drug addiction. However, rapid
assessment indicated that injection drug use occurred in
all districts of the city, and that risk behaviors did not vary
by district, thus the sample could be drawn from any or all
districts. Clients from the National Center for AIDS Pre-
vention, the Syringe Exchange, the Narcotics Anonymous
group, and the NGO Positive Movement assisted with
snowball recruitment in the streets, in discos and other
public places.
St. Petersburg
Rapid assessment indicated that most IDUs live in the
new districts of St. Petersburg (so called "bed-districts"),
and IDUs congregate at metro stations, so it was decided
to recruit the community subjects mainly in those loca-
tions. The old centre of St. Petersburg was the other region
for recruitment. The research field staff drove to those
locations in a van so that study recruits could be inter-
viewed inside the vehicle and be less visible to police or
other citizens.
Bogotá
During rapid assessment, drug injection practices were
most visible among a few specific sub-groups – informal
workers, handicraft and jewelry vendors who were typi-
cally involved in drug-dealing or other illegal activities.
Recruitment from these groups was relatively easy due to
their accessibility. However, there was also evidence that
drug injecting was spreading through diverse social
groups throughout the city, thus snowballing and peer
referral strategies were implemented to access new groups.
Additionally, the study team distributed leaflets asking for
volunteers for the project. Recruits included grade and
high school students, university students, workers in the
informal and formal sectors, handicraft and jewelry ven-
dors, athletes, drug dealers, people involved in other illicit
activities and young people without any known occupa-
tion. Most subjects belonged to low and middle-income
Table 3b: Demographics
Eastern Europe South America
Kharkiv Minsk St. Petersburg Bogota Gran Rosario Rio de Janeiro Santos
n = 438 n = 400 n = 400 n = 301 n = 605 n = 586 n = 362
Female 26% 23% 26% 21% 23% 9% 18%
Age Mean (SD) 25 (5) 24 (5) 24 (5) 24 (7) 28 (8) 32 (10) 29(10)
Median 24 23 23 22 27 30 27
< 25 yrs. 55% 63% 63% 65% 43% 29% 38%
Ethnicity 71% Ukrainian 
24% Russian
75% 
Belarussian 
17% Russian
96% Russian 97% Mestizo 69% White 
24% Mestizo
48% White 
32% Mulatto 
20% Black
not available
Table 3a: Demographics
Africa Asia
Lagos Nairobi Beijing Hanoi Penang
n = 386 n = 348 n = 377 n = 763 n = 228
F e m a l e 1 4 %7 %2 3 % 1 6 %0 %
Age Mean (SD) 37 (6) 29 (7) 30 (7) 28 (7) 35 (9)
Median 36 28 30 27 33
< 25 yrs. 2% 30% 23% 32% 8%
Ethnicity 71% Yoruba 68% Kikuyu 88% Han 99% Kinh 55% Malay 
23%Chinese 21% 
IndianBMC Public Health 2006, 6:54 http://www.biomedcentral.com/1471-2458/6/54
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social levels, and a large number (43%) were supported
by friends or family.
Gran Rosario
The research team identified public places where large
numbers of discarded syringes were found and areas
where drug users congregated. Study subjects were
recruited from a variety of socio-economic groups, per-
sons with permanent employment, temporary work, on
government subsidies, persons supported by friends or
family, persons involved in illegal activities, and street
peddlers.
Rio de Janeiro
Drug use appears in all strata of society. Outreach workers
were able to recruit drug users from many different com-
munities including both middle class neighborhoods and
economically disadvantaged communities. However, it
was clear to the research team that drug users from the
upper classes were considerably undersampled. A van was
used to facilitate travel to different areas, and transporta-
tion expenses were paid to drug users where necessary.
80% of study recruits supported themselves primarily by
income from work.
Santos
As in Rio, drug use is found among all socio-economic
groups, however study subjects were mainly recruited
from the lower and middle classes, including the city's
tenements and slums.
Demographics of study subjects
Tables 3a and 3b present the gender and age breakdown
of all recruits in each of the cities. Females typically com-
prise less than one quarter of the overall sample in each
city; indeed in Lagos, Nairobi, and Rio de Janeiro very few
females were recruited and in Penang there were none.
The proportion of females does not differ much between
the current, former, or never-injectors except in Nairobi
and Hanoi where the proportion of females is higher
among current IDUs than among the other recruits. These
two cities are also the two cities with the highest percent-
age of female sex workers in the IDU sample. In Hanoi all
except one of the never-injectors are male.
Within each city, average age is similar for current, former,
and never-injectors except that never-injectors in Penang
and Santos and current IDUs in Bogotá and Rio de Janeiro
tend to be younger than the other recruits. However, there
are large age differences between sites – the Eastern
Europe and Bogotá recruits tended to be the youngest, and
the Lagos and Penang recruits the oldest. Indeed, in
Bogotá 43% are under 21, and almost a third of Penang
recruits are over 40.
In most cities, drug users on the whole are typically mem-
bers of the ethnic majority groups. However, in Penang
current and former IDUs are far more likely to be from the
minority Chinese and Indian ethnic groups than the
never-IDUs who are primarily Malay. Similarly, in Rosario
current and former IDUs are more likely to be from the
minority Mestizo or indigenous groups than the never-
injectors who are primarily White.
Discussion
The WHO Drug Injection Study Phase II differed from the
phase I study in two important ways. First, it was con-
ducted primarily in developing and transitional countries,
and second, it included non-injecting drug users (both
former injectors and never injectors) as well as current
injecting drug users. The experience with the two studies
suggests that there is much greater cross-site similarity in
the drug use environments in industrialized countries and
much greater cross-site diversity in drug use environments
in developing and transitional countries. Thus, it was rel-
atively easy to obtain "standardized" treatment samples in
phase I cities, and very difficult to do so in many of the
phase II cities. Non-injecting drug users were included in
order to better understand transitions between injecting
and non-injecting drug use, which are of great importance
in some developing countries. Both of these factors
increased the practical difficulties in conducting the study.
The fundamental tension in conducting the study was
between maintaining standardized methods across the
different sites and adapting to local conditions. Recruiting
subjects among drug users entering drug abuse treatment
is an excellent example of this issue. In cities that have a
"reasonably large" treatment capacity (sufficient for 15%
or more of drug users in the local area), free or low cost
treatment, and voluntary entry into treatment, new
entrants into treatment tend to have very high drug use
frequencies and be at high risk for exposure to HIV. Thus,
cross-site comparisons of new entrants into drug abuse
treatment can provide important insights into the risks for
HIV infection among particularly high-risk drug users in
different cities. This "relatively simple" comparison could
not be made for all cities in WHO phase II. For example,
entry into drug abuse treatment was involuntary (reflect-
ing law enforcement activities more than the treatment
needs of the drug users) in Hanoi, Beijing, Penang, and to
a lesser extent in Nairobi. In Lagos and Nairobi, although
voluntary drug treatment was available, the costs were suf-
ficiently high that only a few drug users could afford treat-
ment. In Bogotá, where injection drug use is typically
experimental and sporadic and not the primary reason for
seeking treatment, the numbers of IDUs entering treat-
ment were so small as to make recruiting from treatment
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There were two basic strategies used to address the many
methodological issues that arose during the study. The
first was the use of rapid assessment before conducting the
structured risk behavior and seroprevalence study. The
rapid assessment provided critical information about how
to adapt sampling strategies and questionnaire items to
each local situation. This presented opportunities for
resolving potential problems before they arose during the
survey.
The second strategy was a close working relationship
between the individual participating sites and the New
York Survey Coordinating Center. The latter approved of
all modifications to sampling methods and changes in the
questionnaire. Any changes could be done in "real time"
during the data collection and from the perspective of the
study as a whole rather than having individual sites mak-
ing decisions that might jeopardize the ability to pool the
data across all of the sites.
Conclusion
We certainly would not claim that the use of a rapid
assessment and close coordination of a structured survey
will successfully resolve all problems in attempting to
maintain standardized methods across a wide variety of
sites, but do believe that they are critical for achieving an
acceptable level of standardized data collection across
sites as diverse as those in the WHO Drug Injection Study
Phase II study of HIV and injecting drug use.
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